Apr 5, 2021, 14:49 by

Ceryx Medical, the business behind a revolutionary technology that could significantly change the way patients with serious heart problems are treated, has appointed Chas Taylor, a leading medical devices entrepreneur, as Chairman.

Apr 5, 2021, 14:49 by

COPD Foundation and DevPro Biopharma enter into a strategic alliance to develop more effective treatments for people with chronic lung conditions and get them to patients sooner.

Apr 5, 2021, 14:49 by

Notes to editors Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. RDIF has established joint strategic partnerships with leading international co-investors from over 18 countries attracting over $40 bn of capital. Further information can be found at rdif.ru For more information about the Sputnik vaccine please visit sputnikvaccine.com/ Stelis Biopharma Pvt. Ltd. (Stelis) is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to-end cGMP manufacturing capabilities from drug substance through drug product in all formats and packaging. Stelis is also developing select follow-on biologic products for global markets in niche and commercially attractive disease categories. Stelis has recently forayed into Vaccine manufacturing with a capability to do multiple vaccine types. Stelis’ state-of-the-art research & development facility and 200,000 sq. ft. fully integrated cGMP manufacturing facility are located in Bengaluru, India. Facilities cater to the development and cGMP manufacturing of biologics and injectables conforming to international standards. For more information visit www.stelis.com Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com

Apr 5, 2021, 14:49 by

CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.

Apr 5, 2021, 14:49 by

ENDURADRIVE® Fan System provides peace of mind and unmatched reliability, thanks to its advanced design

Apr 5, 2021, 14:49 by

Formedix announces today the launch of ryze, an innovative all-in-one cloud-based clinical metadata repository (MDR) and study automation platform, specifically developed to accelerate and streamline the design, build and submission of clinical trials in compliance with CDISC and NCI Controlled Terminology.

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

This partnership integrates MyMeds&Me’s validated safety data capture solution into Auxita, enabling healthcare providers, patient support programs and pharmaceutical companies to capture and manage data more efficiently.

Apr 5, 2021, 14:49 by

Apr 1, 2021, 01:00 by User Not Found

Clinical Research News | PatientsLikeMe raises a new round of funding to expand, and several companies get investments for remote patient monitoring and medication adherence. Mount Sinai leads team tasked with decreasing the disparities in cancer trials. And new investment funds for late-stage companies and public health.

Mar 31, 2021, 01:00 by User Not Found

Clinical Research News | Cerevel Therapeutics is looking at new studies in a different way after test-driving an assortment of virtual trial options when the pandemic hit. Remote site initiation visits and remote monitoring will be permanent fixtures moving forward, and the incorporation of home health visits also appears promising, according to Laura Whitmore, director of clinical operations oversight

Mar 30, 2021, 01:00 by User Not Found

Clinical Research News | A panel discussion on the move toward “platform thinking” in pharma roused lively discussion and exchange with attendees at the recent Summit for Clinical Ops Executives (SCOPE). Interest was particularly high in development of a common platform catering to the needs of patients and disconnected from any drug, protocol, or sponsor.

Mar 29, 2021, 01:00 by User Not Found

Clinical Research News | Takeda Pharmaceuticals has developed a digital chatbot assistant to provide integrated and continuous support for patients with chronic diseases at risk of serious event occurrences and frequent emergency room visits. The learnings are expected to help clinical trials become more patient-centric and less labor-intensive to conduct.

Mar 25, 2021, 01:00 by User Not Found

Clinical Research News | Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we believe that the greatest impact of precision oncology has been in the design of early-phase trials.

Mar 24, 2021, 01:00 by User Not Found

Clinical Research News | TransCelerate’s eSource initiative supporting decentralized clinical trials aims to add efficiency to the clinical research process by facilitating the exchange of data between sites and sponsors and “filling the gaps” in the primary data interchange standards governing electronic health record (EHR) systems.

Mar 23, 2021, 01:00 by User Not Found

Clinical Research News | AbbVie is developing a patient burden algorithm to quantify the onus of trial-related procedures on study participants, according to Allam Fakhoury, PharmD, the company’s head of portfolio design and execution, at a presentation he made at last week’s Summit for Clinical Ops Executives (SCOPE).

Mar 22, 2021, 15:12 by User Not Found

Clinical Research News | AstraZeneca has been embracing the use of real-world evidence (RWE) for clinical research to help overcome some of the new and perennial challenges in moving medicines to market. The company has been actively using RWE to optimize study protocols, assess new opportunities, employ external arms/comparators, enable pragmatic clinical trials, and transform endpoints, she reports.